{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:45:44Z","timestamp":1789685144860,"version":"4.0.1"},"reference-count":154,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":11093,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1981,9,10]]},"abstract":"<jats:p>Maprotiline, a tetracyclic antidepressant with sedative properties, exhibits strong inhibitory effects on norepinephrine uptake across nerve cell membranes but interferes relatively little with serotoninergic mechanisms. The biological half\u2010life of unchanged maprotiline in blood averages 43 hours. Though several studies suggest a more rapid onset of antidepressant effects with maprotiline than with amitriptyline or imipramine, this issue remains unresolved.<\/jats:p><jats:p>The adverse effect profile of maprotiline is similar to that of the tricyclic antidepressants, except that rashes are about twice as frequent with maprotiline as with amitriptyline or imipramine. The most frequent adverse reactions are anticholinergic effects and sedation. Data suggest less frequent and severe anticholinergic side effects with maprotiline than with amitriptyline. Maprotiline may be less likely to induce orthostatic hypotension and tachycardia than standard tricyclic antidepressants, but clinically important differences in cardiovascular effects remain to be conclusively demonstrated. Many patients benefit from the convenience of once daily dosing.<\/jats:p><jats:p>Maprotiline is comparable in antidepressant efficacy to the tricyclic antidepressants.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1981.tb03559.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T08:27:30Z","timestamp":1450254450000},"page":"121-138","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects, and Efficacy of the Antidepressant Maprotiline Hydrochloride"],"prefix":"10.1002","volume":"1","author":[{"given":"Barbara G.","family":"Wells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Gelenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"75","volume-title":"Chemotherapy in psychiatry","author":"Baldessarini RJ.","year":"1977"},{"issue":"3","key":"e_1_2_1_3_2","first-page":"16","article-title":"The pharmacokinetic properties of maprotiline (Ludiomil) in man","author":"Riess W","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_4_2","first-page":"486","article-title":"Chemische konstitution und klinische wirkung von antidepressiven pharmaka","volume":"14","author":"Bente D","year":"1964","journal-title":"Arzneim Forsch"},{"key":"e_1_2_1_5_2","first-page":"113","volume-title":"Depressive illness","author":"Delina\u2010Stula A.","year":"1972"},{"key":"e_1_2_1_6_2","first-page":"611","article-title":"Richerche pharmacologiche sulla maprotilinia nuova sostanza ad azione anti\u2010depressiva","volume":"112","author":"Baltzer V","year":"1973","journal-title":"Bull Chim Pharm"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3565(25)12878-4","article-title":"Effects of various centrally acting drugs on fighting behavior in mice","volume":"125","author":"Tedeschi RE","year":"1959","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"e_1_2_1_8_2","first-page":"2","article-title":"Maprotiline \u2014 its position as an antidepressant in the light of recent neuropharmacological and neurochemical findings","author":"Maitre L","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057800600601"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404368"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.211589"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.725608"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(79)90035-X"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01250331"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7384806"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(71)90216-4"},{"key":"e_1_2_1_17_2","first-page":"297","volume-title":"Serotonin \u2014 New vistas; histochemistry and pharmacology","author":"Maitre L","year":"1974"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00403565"},{"issue":"4","key":"e_1_2_1_19_2","first-page":"14","article-title":"Clomipramine and maprotiline on human platelet uptake of 5\u2010hydroxytryp\u2010tamine and dopamine in vitro: What relevance to their antidepressive and other central actions?","volume":"53","author":"Turner P","year":"1977","journal-title":"Postgrad Med J"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057900700511"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01579067"},{"key":"e_1_2_1_22_2","first-page":"91","article-title":"Comparison of the effects of maprotiline (Ludiomil) and clomipramine (Anafranil) on serotinin uptake and tryptophan\u2010binding in plasma","volume":"11","author":"Greengrass PM","year":"1976","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(68)90079-4"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01922568"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770220071008"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01990085"},{"key":"e_1_2_1_27_2","first-page":"192","article-title":"Pharmacological studies of drug action on CNS, with special reference to effects of maprotiline","volume":"11","author":"Shibuya T","year":"1975","journal-title":"Int J Clin Pharmacol"},{"key":"e_1_2_1_28_2","first-page":"180","volume-title":"Depressive illness. Diagnosis, assessment, treatment","author":"Jovanovic UJ","year":"1972"},{"key":"e_1_2_1_29_2","first-page":"209","article-title":"Categories of psychotropic drug effects on sleep EEG and EOG","volume":"16","author":"Jovanovic UJ.","year":"1974","journal-title":"Act Nerv Super"},{"key":"e_1_2_1_30_2","first-page":"110","article-title":"EEG changes in treatment with maprotiline","volume":"15","author":"Misurec J","year":"1973","journal-title":"Act Nerv Super"},{"key":"e_1_2_1_31_2","first-page":"451","article-title":"Maprotiline (Ludiomil, Ciba 34,276\u2010Ba) and imipramine in depressed outpatients: A double\u2010blind clinical study","volume":"19","author":"Singh AN","year":"1976","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(59)91811-2"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.115.12.1117"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)90876-2"},{"key":"e_1_2_1_35_2","first-page":"2052","article-title":"Side effects of maprotiline (letter)","volume":"48","author":"Jacobs D","year":"1974","journal-title":"S Afr Med J"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431733"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1959.tb49242.x"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb04570.x"},{"key":"e_1_2_1_39_2","first-page":"485","article-title":"Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine, and amitriptyline","volume":"14","author":"Koella WP","year":"1979","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_40_2","first-page":"4","article-title":"The effect of maprotiline and imipramine on sleep cycles in rats","volume":"17","author":"Benesova O.","year":"1975","journal-title":"Act Nerv Super"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760240077006"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(68)90037-X"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(79)90124-2"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094559"},{"key":"e_1_2_1_45_2","first-page":"651","article-title":"Comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake","volume":"59","author":"Harper B","year":"1977","journal-title":"J Pharmacol"},{"key":"e_1_2_1_46_2","first-page":"17","article-title":"Maprotiline: An effective tetracyclic antidepressant","volume":"8","author":"Ayd F.","year":"1973","journal-title":"Int Drug Ther Newsletter"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1979.tb07834.x"},{"key":"e_1_2_1_48_2","first-page":"161","volume-title":"Depressive illness. Diagnosis, assessment treatment","author":"Reale A","year":"1972"},{"key":"e_1_2_1_49_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/030006057600400106","article-title":"Antidepressant treatment with maprotiline in the management of emotional disturbances in patients with acute myocardial infarction: A controlled study","volume":"4","author":"Selvini A","year":"1976","journal-title":"J Int Med Res"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03280300045019"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6138.666-a"},{"key":"e_1_2_1_52_2","first-page":"738","article-title":"A controlled evaluation of a tetracyclic (maprotiline) and a tricyclic (imipramine) antidepressant and their effects on the heart","volume":"25","author":"Mielke DH","year":"1979","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_53_2","first-page":"172","volume-title":"Depressive illness. Diagnosis, assessment, treatment","author":"Geisler L","year":"1972"},{"key":"e_1_2_1_54_2","first-page":"19","volume-title":"Research and clinical investigation in depression","author":"Riess W.","year":"1976"},{"key":"e_1_2_1_55_2","unstructured":"LuscombeDK JonesRB BeaumontGet al.Plasma concentrations of maprotiline in man (abstract). Presented at VI World Congress of Psychiatry. Honolulu Hawaii 1977Sept. 3."},{"key":"e_1_2_1_56_2","first-page":"237","volume-title":"Classification and prediction of outcome of depression","author":"Angst J","year":"1973"},{"issue":"4","key":"e_1_2_1_57_2","first-page":"155","article-title":"Clinical response in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response","volume":"53","author":"Mulgirigama LD","year":"1977","journal-title":"Postgrad Med J"},{"issue":"4","key":"e_1_2_1_58_2","first-page":"101","article-title":"Efficacy, side effects, plasma and blood levels of maprotiline","volume":"5","author":"Miller PI","year":"1977","journal-title":"J Int Med Res"},{"key":"e_1_2_1_59_2","first-page":"90","volume-title":"Research and clinical investigation in depression","author":"Forrest WA.","year":"1976"},{"key":"e_1_2_1_60_2","first-page":"233","volume-title":"Depression: Behavioral, biochemical, diagnostic, and treatment concepts","author":"Weissman MM.","year":"1976"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007997609110615"},{"key":"e_1_2_1_62_2","first-page":"234","volume-title":"Depressive illness. Diagnosis, assessment, and treatment","author":"Guz I.","year":"1972"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1975.tb105901.x"},{"issue":"4","key":"e_1_2_1_64_2","first-page":"112","article-title":"Maprotiline (Ludiomil) in depression: A report of a monitored release study in general practice","volume":"5","author":"Forrest WA.","year":"1977","journal-title":"J Int Med Res"},{"issue":"2","key":"e_1_2_1_65_2","first-page":"126","article-title":"Maprotiline (Ludiomil\u00ae): Side\u2010effects and overdosage","volume":"3","author":"Jukes AM.","year":"1975","journal-title":"J Int Med Res"},{"issue":"2","key":"e_1_2_1_66_2","first-page":"61","article-title":"Continental hospital studies with maprotiline (Ludiomil) (1)","volume":"3","author":"Lauritsen B.","year":"1975","journal-title":"J Int Med Res"},{"issue":"2","key":"e_1_2_1_67_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/030006057500300209","article-title":"A double\u2010blind general practice trial of maprotiline (Ludiomil) against amitriptyline in the treatment of reactive depression","volume":"3","author":"Murphy JE.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_68_2","first-page":"114","volume-title":"Research and clinical investigation in depression","author":"Silverstone T","year":"1976"},{"key":"e_1_2_1_69_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000468194","article-title":"Double\u2010blind comparison of maprotiline and amitriptyline in the treatment of depressive illness","volume":"10","author":"Trick KLK.","year":"1975","journal-title":"Int Pharmacopsychiatry"},{"key":"e_1_2_1_70_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.5694\/j.1326-5377.1975.tb111845.x","article-title":"A controlled study of a tetracyclic antidepressant \u2014 maprotiline (Ludiomil)","volume":"1","author":"Kessell A","year":"1975","journal-title":"Med J Aust"},{"issue":"2","key":"e_1_2_1_71_2","first-page":"67","article-title":"Double\u2010blind comparison of maprotiline (Ludiomil) with amitriptyline in the treatment of depressive illness","volume":"3","author":"Trick KLK.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_72_2","first-page":"245","volume-title":"Depressive illness. Diagnosis, assessment, and treatment","author":"Angst J","year":"1972"},{"key":"e_1_2_1_73_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000468274","article-title":"Clinical comparative evaluation of maprotiline, a new anti\u2010depressant drug","volume":"6","author":"Balestrieri A","year":"1971","journal-title":"Int Pharmacopsychiatry"},{"issue":"2","key":"e_1_2_1_74_2","first-page":"79","article-title":"A comparison between maprotiline (Ludiomil) and imipramine in the treatment of depressive illness in the elderly","volume":"3","author":"Middleton RSW.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_75_2","first-page":"47","article-title":"Maprotiline and amitriptyline in the treatment of depressive illness","volume":"48","author":"Levin A.","year":"1974","journal-title":"S Afr Med J"},{"issue":"4","key":"e_1_2_1_76_2","first-page":"25","article-title":"A comparison of maprotiline (Ludiomil) and amitriptyline (2)","volume":"5","author":"Mindham BAE.","year":"1977","journal-title":"J Int Med Res"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1975.tb00038.x"},{"key":"e_1_2_1_78_2","first-page":"1530","article-title":"Clinical evaluation of the antidepressants maprotiline and amitriptyline: A double\u2010blind controlled trial","volume":"48","author":"Marais GFT.","year":"1974","journal-title":"S Afr Med J"},{"issue":"4","key":"e_1_2_1_79_2","first-page":"51","article-title":"A comparison of maprotiline (Ludiomil) and slow release amitriptyline (Tryptizol SR)","volume":"5","author":"McMillan WP.","year":"1977","journal-title":"J Int Med Res"},{"issue":"4","key":"e_1_2_1_80_2","first-page":"34","article-title":"A comparison of Ludiomil, Tryptizol, and Lentizol","volume":"5","author":"Murphy JE.","year":"1977","journal-title":"J Int Med Res"},{"issue":"2","key":"e_1_2_1_81_2","first-page":"89","article-title":"A clinical trial of maprotiline (Ludiomil) in the treatment of depressive patients in general practice and the psychiatric clinic","volume":"3","author":"Crawford R","journal-title":"J Int Med Res"},{"key":"e_1_2_1_82_2","first-page":"611","article-title":"Double\u2010blind, between patient trial on antidepressant effect of maprotiline in comparison with imipramine","volume":"68","author":"Paprocki J","year":"1974","journal-title":"A Folha Medica"},{"key":"e_1_2_1_83_2","first-page":"253","volume-title":"Depressive illness. Diagnosis, assessment, treatment","author":"Pinto S","year":"1972"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057500300209"},{"issue":"2","key":"e_1_2_1_85_2","first-page":"120","article-title":"A comparison between daily and nightly dose regimen of amitriptyline and maprotiline (Ludiomil) in the treatment of reactive depression in general practice","volume":"3","author":"Forrest WA.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197713050-00001"},{"key":"e_1_2_1_87_2","first-page":"95","volume-title":"Research and clinical investigation in depression","author":"Murphy JE.","year":"1976"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057700500107"},{"key":"e_1_2_1_89_2","unstructured":"Ciba\u2010Geigy Corporation.Background information packet submitted to Food and Drug Administration Psychopharmacological Agents Advisory Committee by Ciba\u2010Geigy Corporation May 14 1979."},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92006-7"},{"key":"e_1_2_1_91_2","first-page":"21","volume-title":"Meyler's side effects of drugs","author":"Edelstein EL.","year":"1980"},{"key":"e_1_2_1_92_2","first-page":"483","article-title":"Agranulocytosis associated with tricyclics","volume":"39","author":"Albertine RS","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_93_2","first-page":"782","article-title":"Toxicity and effects on reproduction in animals of the new antidepressant maprotiline (Ludiomil)","volume":"112","author":"Hess R","year":"1973","journal-title":"Boll Chim Farm"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1974.tb08208.x"},{"key":"e_1_2_1_95_2","first-page":"691","article-title":"A double\u2010blind comparative clinical trial with Ludiomil (CIBA 34, 276Ba) and amitriptyline in new admitted depressed patients","volume":"15","author":"Amin M","year":"1973","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.128.5.479"},{"key":"e_1_2_1_97_2","first-page":"1621","article-title":"Clinical study of maprotiline in the treatment of depressive conditions","volume":"7","author":"Millier C","year":"1975","journal-title":"Psychol Med"},{"issue":"2","key":"e_1_2_1_98_2","first-page":"101","article-title":"Once dosage with maprotiline","volume":"3","author":"Bartholini E.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_99_2","first-page":"463","article-title":"A double\u2010blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly\u2010admitted depressed patients","volume":"19","author":"Lehmann HE","year":"1976","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_100_2","first-page":"1283","article-title":"Klinische erfahrungen mit dem neuen antidepressivum maprotiline 34,276Ba","volume":"24","author":"Floru L.","year":"1973","journal-title":"Med Welt"},{"key":"e_1_2_1_101_2","first-page":"154","article-title":"Delirious syndrome during treatment with Ludiomil","volume":"26","author":"Heckl RW.","year":"1975","journal-title":"Med Welt"},{"key":"e_1_2_1_102_2","unstructured":"HattabJR.The cardiovascular effects of Ludiomil in comparison with those of some tricyclic antidepressants. Paper presented at the Ludiomil Symposium. Malta 1976November."},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6182.102"},{"key":"e_1_2_1_104_2","first-page":"2009","article-title":"Side effects of maprotiline (letter)","volume":"48","author":"Daneel AB","year":"1974","journal-title":"S Afr Med J"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6126.1523"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6142.961-c"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6149.1430-d"},{"key":"e_1_2_1_108_2","first-page":"201","volume-title":"Depression \u2014 the biochemical and physiological role of Ludiomil","author":"Burley DM.","year":"1977"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1978.tb04486.x"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90797-7"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92852-6"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106377"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91123-1"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5852.522"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1967.03130230099018"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1974.tb00219.x"},{"issue":"2","key":"e_1_2_1_117_2","first-page":"55","article-title":"Interactions between post\u2010ganglionic sympathetic blocking drugs and antidepressants","volume":"3","author":"Smith AJ","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197012312832703"},{"key":"e_1_2_1_119_2","first-page":"372P","article-title":"Effects of tricyclic antidepressants on drug metabolism","volume":"44","author":"O'Malley K","year":"1972","journal-title":"Br J Pharmacol"},{"key":"e_1_2_1_120_2","first-page":"626","article-title":"The anticoagulant action of Sintrom\u00ae and the blood concentration of Ludiomil\u00ae in simultaneous administration","volume":"70","author":"Michot F","year":"1975","journal-title":"Med Klin"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6076.1573"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6081.260-a"},{"issue":"4","key":"e_1_2_1_123_2","first-page":"122","article-title":"Practical considerations in the use of maprotiline (Ludiomil) in general practice","volume":"5","author":"Lloyd AH.","year":"1977","journal-title":"J Int Med Res"},{"key":"e_1_2_1_124_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750210060012"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760190019001"},{"key":"e_1_2_1_126_2","unstructured":"SchatzbergAF RosenbaumAH OrsulakPJet al.MHPG as a predictor of antidepressant response. Paper presented at 133rd Annual Meeting American Psychiatric Association. San Francisco 1980May."},{"issue":"2","key":"e_1_2_1_127_2","first-page":"84","article-title":"A comparison of maprotiline (Ludiomil) and placebo in the treatment of depression","volume":"3","author":"Jukes AM.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_128_2","first-page":"446","article-title":"A double\u2010blind study of maprotiline (Ludiomil) and imipramine in depressed outpatients","volume":"22","author":"Claghorn JL.","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_129_2","first-page":"881","article-title":"Clinical trials of the treatment of depressive illness. Report to the Medical Research Council by its Clinical Psychiatry Committee","volume":"1","author":"British Medical Research Council.","year":"1965","journal-title":"Br Med J"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(66)90012-4"},{"key":"e_1_2_1_131_2","first-page":"267","article-title":"Clinical pharmacology of imipramine and related antidepressant compounds","volume":"3","author":"Klerman GL","year":"1967","journal-title":"Int J Psychiatry"},{"key":"e_1_2_1_132_2","unstructured":"PoldingerW GruterW.A new antidepressant (Ciba 34 276 Ba) for the treatment of suicidal patients. In:LitmanRE ed. Proceedings 6th International Conference for Suicide Prevention. Mexico D.F. Mexico Dec 58 1972:107\u201311."},{"key":"e_1_2_1_133_2","first-page":"353","article-title":"Maprotiline: Short and long\u2010term therapy (1)","volume":"69","author":"Paprocki J","year":"1974","journal-title":"A Folha Med"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057600400309"},{"key":"e_1_2_1_135_2","first-page":"256","volume-title":"Masked depression","author":"Pinto S","year":"1973"},{"key":"e_1_2_1_136_2","article-title":"On the antidepressive effect of Ciba 34,276\u2010Ba. Observations on 562 cases (abstract). V. Congreso Mundial de Psiquiatria","author":"Gruter W.","year":"1971","journal-title":"Ciudad de Mexico"},{"key":"e_1_2_1_137_2","first-page":"77","volume-title":"Research and clinical investigation in depression","author":"Forrest WA.","year":"1976"},{"issue":"4","key":"e_1_2_1_138_2","first-page":"1","article-title":"A comparison of high and low dosage regimes of maprotiline (Ludiomil)","volume":"5","author":"Donald JF.","year":"1977","journal-title":"J Int Med Res"},{"key":"e_1_2_1_139_2","first-page":"231","volume-title":"Depression in everyday practice. An international symposium. St","author":"Danhorn R.","year":"1974"},{"issue":"4","key":"e_1_2_1_140_2","first-page":"22","article-title":"A comparison of maprotiline (Ludiomil) and amitriptyline","volume":"5","author":"Dell AJ.","year":"1977","journal-title":"J Int Med Res"},{"issue":"5","key":"e_1_2_1_141_2","first-page":"77S","article-title":"Differential effects on suicidal ideation of mainserin, maprotiline, and amitriptyline","author":"Montgomery S","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_1_142_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1974.tb93257.x"},{"issue":"2","key":"e_1_2_1_143_2","first-page":"71","article-title":"A double\u2010blind comparative clinical trial of maprotiline (Ludiomil) and amitriptyline","volume":"3","author":"Mathur GN.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057500300610"},{"issue":"2","key":"e_1_2_1_145_2","first-page":"75","article-title":"A controlled comparison of maprotiline (Ludiomil) with imipramine avoiding observer bias","volume":"3","author":"Levine S.","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1979.tb01618.x"},{"key":"e_1_2_1_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(76)90022-5"},{"key":"e_1_2_1_148_2","first-page":"279","article-title":"A comparison of maprotiline and amitriptyline in the treatment of depression in general practice","volume":"218","author":"Silverstone JT","year":"1977","journal-title":"Practitioner"},{"key":"e_1_2_1_149_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/070674377702200106","article-title":"Maprotiline \u2014 a double\u2010blind study of a new tetracyclic antidepressant in severe depression","volume":"22","author":"Molnar G.","year":"1977","journal-title":"Can Psychiatr Assoc J"},{"key":"e_1_2_1_150_2","first-page":"209","volume-title":"Depressive illness. Diagnosis, assessment, and treatment","author":"Welner J.","year":"1972"},{"key":"e_1_2_1_151_2","first-page":"667","article-title":"Infusion therapy of depressive states with Ludiomil","volume":"126","author":"Dorninger F","year":"1976","journal-title":"Wien Med Wochenschr"},{"key":"e_1_2_1_152_2","first-page":"108","volume-title":"Depression in everyday practice","author":"Poldinger W.","year":"1974"},{"key":"e_1_2_1_153_2","first-page":"1251","article-title":"Clinical trials of a new antidepressant: Ludiomil","volume":"7","author":"Volmat R","year":"1975","journal-title":"Psychol Med"},{"issue":"4","key":"e_1_2_1_154_2","first-page":"11","article-title":"The treatment of depression comparing divided and single doses of maprotiline (Ludiomil)","volume":"5","author":"Waxman D.","year":"1977","journal-title":"J Int Med Res"},{"key":"e_1_2_1_155_2","first-page":"644","article-title":"Grundlegende probleme bei der antidepressivaprufung","volume":"21","author":"Immich H","year":"1971","journal-title":"Arzneim Forsch"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1981.tb03559.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1981.tb03559.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1981.tb03559.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:33:30Z","timestamp":1761064410000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1981.tb03559.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,9,10]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,9,10]]}},"alternative-id":["10.1002\/j.1875-9114.1981.tb03559.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1981.tb03559.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,9,10]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}